Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Atherosclerosis. 2012 Nov 28;226(2):483–489. doi: 10.1016/j.atherosclerosis.2012.11.020

Table 3.

Adiponectin and MI (Hazard Ratio, 95% Confidence Interval), N=230 events

Adiponectin Model 1 Model 2 Model 3 Model 4
Continuous 1.03 (1.01–1.05) 0.99 (0.97–1.01) 1.02 (1.00–1.05) 1.03 (1.00–1.06)
Quartile 1 0.74 (0.53–1.04) 1.32 (0.90–1.93) 0.78 (0.51–1.20) 0.54 (0.32–0.92)
Quartile 2 0.54 (0.37–0.78) 0.91 (0.61–1.36) 0.54 (0.35–0.85) 0.41 (0.24–0.71)
Quartile 3 0.64 (0.44–0.91) 0.85 (0.59–1.22) 0.63 (0.42–0.93) 0.67 (0.42–1.06)
Quartile 4 ref ref ref ref

Model 1: Univariate

Model 2: Adjusting for age, sex, race/ethnicity

Model 3: Adjusting for age, sex, race/ethnicity, smoking, hypertension, diabetes, low density lipoprotein cholesterol, high density lipoprotein cholesterol, triglycerides, waist circumference, moderate alcohol use, moderate-heavy physical activity, previous cardiac disease history

Model 4: Adjusting for the variables in model 3 + hsCRP (N=2091)